Confirming the Diagnosis and Maternal 3-MCC
At a Glance
A positive newborn screen for 3-MCC often indicates that the mother, rather than the baby, has the condition. Doctors confirm the diagnosis by testing the blood and urine of both the mother and infant to see where the metabolic markers originate. Breastfeeding is generally safe.
Confirming a diagnosis of 3-MCC deficiency involves a detective-like process. Because the initial newborn screen is just a “smoke detector,” doctors must now look for the “fire”—and determine if that fire is in the baby or the mother [1][2].
The “Maternal 3-MCC” Phenomenon
One of the most surprising parts of a 3-MCC diagnosis is that it often reveals a condition in the mother rather than the infant. This happens because of the placenta, the organ connecting the mother and baby during pregnancy.
If a mother has 3-MCC deficiency, her body produces high levels of a marker called C5-OH (3-hydroxyisovalerylcarnitine) [3][4]. This marker travels through the placenta into the baby’s bloodstream. When the baby is born, the newborn screen detects the mother’s C5-OH that is still circulating in the baby’s system [1][5]. In these cases, the baby’s own metabolism is working perfectly fine, but the screen reflects the mother’s metabolic “signature” [2][6].
It generally takes a few weeks for the mother’s markers to completely “wash out” of the baby’s system. During this time, the baby’s blood spot tests will show decreasing levels of C5-OH.
Can I Still Breastfeed?
A common and terrifying concern for mothers is whether their breast milk is safe, given that their body produces “toxic” byproducts. Yes, it is generally safe to continue breastfeeding. Breastfeeding is heavily encouraged, though your doctor will monitor the baby’s carnitine levels to ensure they are getting what they need [2][7]. Do not stop breastfeeding without consulting your metabolic specialist.
The Three Pillars of Testing
To get a clear answer, doctors use three main types of tests for both the mother and the baby:
- Acylcarnitine Profile (Blood Spot): This is a repeat of the newborn screen but more detailed. It specifically measures the C5-OH level. If the level is high in the mother and dropping in the baby over a few weeks, it strongly suggests the mother is the one with 3-MCC [1][8].
- Urine Organic Acids: This test looks for specific “acid” byproducts that build up when the 3-MCC enzyme isn’t working. Doctors look for two specific markers: 3-MCG (3-methylcrotonylglycine) and 3-HIVA (3-hydroxyisovaleric acid) [9][10].
- Genetic Testing: This is the “gold standard” for confirmation. Scientists look at two specific genes: MCCC1 and MCCC2 [11][9]. Everyone has two copies of these genes. To have 3-MCC deficiency, both copies of either MCCC1 or MCCC2 must have a mutation (change) [9][6].
How Doctors Solve the Puzzle
The medical team compares the results from the mother and the baby:
| Test Result | Likely Conclusion | Next Steps |
|---|---|---|
| Baby’s Urine: Normal Mother’s Urine: High 3-MCG/3-HIVA |
Maternal 3-MCC: The baby is healthy; the screen was triggered by the mother [7]. | Retest baby’s blood to confirm washout. Assess mother for carnitine. |
| Baby’s Urine: High 3-MCG/3-HIVA Mother’s Urine: Normal |
Infant 3-MCC: The baby has the condition [3]. | Institute Sick Day Protocols and infant carnitine supplementation. |
| Genetic Test: Two mutations in the baby | Confirmed Infant 3-MCC [12]. | Long-term follow-up with metabolic genetics. |
Guidance for Diagnosed Mothers
If you are diagnosed with maternal 3-MCC, you might be wondering about your own health. While most mothers are asymptomatic, doctors will monitor you for secondary carnitine deficiency, which can cause fatigue or muscle weakness [13][4]. You may be prescribed an L-carnitine supplement. You should also ask your doctor if you need a simplified “sick day protocol” for yourself during severe illnesses, and be aware that any future children you have will likely trigger the same positive newborn screen [6].
Common questions in this guide
Why did my healthy baby test positive for 3-MCC on the newborn screen?
Is it safe to breastfeed if I am diagnosed with maternal 3-MCC?
How do doctors figure out if the mother or the baby has 3-MCC?
Do mothers with 3-MCC need any treatment or supplements?
What does the genetic test for 3-MCC look for?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.When will we have the results of the mother's urine and blood tests to compare with the baby's?
- 2.If the baby's urine test is normal but the blood test is high, does that confirm it's coming from the mother?
- 3.Are there any other conditions, like Biotinidase deficiency, that could cause these same test results?
- 4.If I (the mother) am diagnosed with maternal 3-MCC, do I need to start taking L-carnitine supplements immediately?
- 5.Do we need to continue follow-up testing for the baby if the mother's diagnosis is confirmed?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (13)
- 1
Primary and maternal 3-methylcrotonyl-CoA carboxylase deficiency: insights from the Israel newborn screening program.
Rips J, Almashanu S, Mandel H, et al.
Journal of inherited metabolic disease 2016; (39(2)):211-7 doi:10.1007/s10545-015-9899-4.
PMID: 26566957 - 2
Maternal Inborn Errors of Metabolism Detected in Expanded Newborn Metabolic Screening.
Tin O, Zübarioğlu T, Cansever MŞ, et al.
Turkish archives of pediatrics 2023; (58(4)):382-387 doi:10.5152/TurkArchPediatr.2023.23009.
PMID: 37317575 - 3
Newborn screening and genetic diagnosis of 3-methylcrotonyl-CoA carboxylase deficiency in Quanzhou,China.
Lin W, Wang K, Chen Y, et al.
Molecular genetics and metabolism reports 2024; (40()):101127 doi:10.1016/j.ymgmr.2024.101127.
PMID: 39188588 - 4
A Study of Maternal Patients Diagnosed with Inborn Errors of Metabolism Due to Positive Newborn Mass Screening in Their Newborns.
Onuki T, Hiroshima S, Sawano K, et al.
Children (Basel, Switzerland) 2023; (10(8)) doi:10.3390/children10081341.
PMID: 37628339 - 5
Beyond newborn screening: the role of reverse cascade testing in familial disease detection.
Gaviglio A, Petritis K, Tagi V, et al.
Critical reviews in clinical laboratory sciences 2025; 1-11 doi:10.1080/10408363.2025.2527288.
PMID: 40673334 - 6
An asymptomatic father diagnosed with 3-methylcrotonyl-CoA carboxylase deficiency following his son newborn screening test.
Terracciano R, Ruoppolo M, Barretta F, et al.
Molecular genetics and metabolism reports 2024; (40()):101116 doi:10.1016/j.ymgmr.2024.101116.
PMID: 39055105 - 7
Maternal 3-methylcrotonyl-coenzyme A carboxylase deficiency with elevated 3-hydroxyisovalerylcarnitine in breast milk.
Cho KL, Kim YJ, Yang SH, et al.
Korean journal of pediatrics 2016; (59(Suppl 1)):S41-S44 doi:10.3345/kjp.2016.59.11.S41.
PMID: 28018443 - 8
Development of Second-Tier Liquid Chromatography-Tandem Mass Spectrometry Analysis for Expanded Newborn Screening in Japan.
Shigematsu Y, Yuasa M, Ishige N, et al.
International journal of neonatal screening 2021; (7(3)) doi:10.3390/ijns7030044.
PMID: 34287228 - 9
Biochemical and molecular characterization of 3-Methylcrotonylglycinuria in an Italian asymptomatic girl.
Cozzolino C, Villani GR, Frisso G, et al.
Genetics and molecular biology 2018; (41(2)):379-385 doi:10.1590/1678-4685-GMB-2017-0093.
PMID: 29767664 - 10
Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency in Zhejiang province, China.
Cheng Y, Chen P, Yu Z, et al.
Clinica chimica acta; international journal of clinical chemistry 2023; (542()):117266 doi:10.1016/j.cca.2023.117266.
PMID: 36822454 - 11
A Unique Presentation of 3-Methylcrotonyl-CoA Carboxylase Deficiency.
Jagadish A, Sclater K, Lapinski T, et al.
Cureus 2023; (15(5)):e39401 doi:10.7759/cureus.39401.
PMID: 37362523 - 12
Next generation sequencing as a follow-up test in an expanded newborn screening programme.
Smon A, Repic Lampret B, Groselj U, et al.
Clinical biochemistry 2018; (52()):48-55 doi:10.1016/j.clinbiochem.2017.10.016.
PMID: 29111448 - 13
An acute life-threatening episode of rhabdomyolysis, renal failure, altered mental status and hyperammonemia in an adult with 3-methylcrotonyl-CoA carboxylase deficiency.
McGowan R, Yano S
Molecular genetics and metabolism reports 2024; (41()):101138 doi:10.1016/j.ymgmr.2024.101138.
PMID: 39286770
This page explains 3-MCC diagnostic testing and the maternal 3-MCC phenomenon for educational purposes. Always consult your metabolic specialist or pediatrician to interpret your newborn screening and diagnostic results.
Get notified when new evidence is published on 3-methylcrotonyl-CoA carboxylase deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.